logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Manish A. Shah

Weill Cornell Medicine
H指数:82
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities

患者来源的类器官跨越癌症揭示了保守的肿瘤异质性和可操作的药物治疗易感性

Science Advances
IF12.5
2026-06-260
OA
Hui-Hsuan Kuo; Bhavneet Bhinder; Hamza N. Gokozan; Kathryn Gorski; Pooja Chandra; Jyothi Manohar; Daniela Guevara; John Otilano; Jenna Moyer; Marvel Tranquille; Sarah Ackermann; Jared Capuano; Cynthia Cheung; Thomas A. Caiazza; Phoebe L. Reuben; Anastasia Murray Tsomides; Adriana Irizarry; Michael Sigouros; David Wilkes; Abigail King; Troy Kane; Majd Al Assaad; Wael Al Zoughbi; Kentaro Ohara; Joonghoon Auh; Peter Waltman; Florencia P. Madorsky Rowdo; Enrique Podaza; Valerie Gallegos; John Nguyen; Raehash Shah; Manish Shah; Allyson Ocean; Douglas Scherr; Nasser Altorki; Melissa Frey; Ana M. Molina; Lisa Newman; Vivan Bea; Eloise Chapman-Davis; Marcus D. Goncalves; Ashish Saxena; Parul J. Shukla; Kevin Holcomb; Rachel Simmons; Scott Tagawa; Jonathan H. Zippin; Evelyn Cantillo; Rohit Chandwani; Melissa Davis; Kelly Garrett; Pashtoon M. Kasi; Jennifer Marti; David Nanus; Jones T. Nauseef; Elizabeth Popa; Momin T. Siddiqui; Alicia Alonso; Cora N. Sternberg; Bishoy M. Faltas; Olivier Elemento; Juan Miguel Mosquera; Andrea Sboner; M. Laura Martin
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort

全基因组测序方法评估泛癌种队列中的同源重组缺陷

Communications Medicine
IF6.3
2026-01-120
OAAI
Majd Al Assaad; Kevin Hadi; Max F. Levine; Daniela Guevara; Minal Patel; Marvel Tranquille; Abigail King; John Otilano; Alissa Semaan; Gunes Gundem; Juan S. Medina-Martínez; Michael Sigouros; Jyothi Manohar; Hui-Hsuan Kuo; David C. Wilkes; Eleni Andreopoulou; Eloise Chapman-Davis; Scott T. Tagawa; Andrea Sboner; Allyson J. Ocean; Manish A. Shah; Elli Papaemmanuil; Cora N. Sternberg; Kevin Holcomb; David M. Nanus; Olivier Elemento; Juan Miguel Mosquera
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients

Ia/b期多中心研究：BPM31510IV单药治疗和联合化疗在实体瘤患者中靶向线粒体代谢/瓦伯格效应的应用

Cancer Research Communications
IF0
2025-12-010
OA
Subbiah, Vivek; Yu, Peter P.; Sarangarajan, Rangaprasad; Kiebish, Michael A.; Rodrigues, Leonardo O.; Miller, Gregory M.; Akmaev, Viatcheslav R.; Luan, Shen; McCook, John P.; Tanna, Nikunj; Reilly, Tracey; Chen, Emily; Bussberg, Valerie; Ravipaty, Shobha; Vishnudas, Vivek K.; Gesta, Stephane; Lucius, David; Bruce, Can; Hazarika, Suwagmani; Lyng, Arianne; Klotz, Allison; Tolstikov, Vladimir; Stevens, Janice; Chua, Victoria S.; Granger, Elder; Tekumalla, Poornima K.; Benaim, Ely; Modur, Vijay; Rudoltz, Marc S.; Song, Paul Y.; Tagawa, Scott T.; Hendifer, Andrew; Chawla, Sant P.; Shah, Manish A.; Hong, David S.; Zinner, Ralph; Narain, Niven R.; Kundranda, Madappa N.
Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survival

整合转录组学和单细胞蛋白质表征的结直肠癌研究，阐明了与总生存期相关的不同肿瘤免疫微环境。

pathology research and practice
IF0
2025-07-280
PRE
Erika Hissong; Bhavneet Bhinder; Junbum Kim; Kentaro Ohara; Hiranmayi Ravichandran; Majd Al Assaad; Sarah Elsoukkary; Michael Shusterman; Uqba Khan; Kenneth Wha Eng; Rohan Bareja; Jyothi Manohar; Michael Sigouros; Andre F. Rendeiro; Jose Jessurun; Allyson J. Ocean; Andrea Sboner; Olivier Elemento; Juan Miguel Mosquera; Manish A. Shah
Comparison of left atrial appendage closure and oral anti-coagulation after catheter ablation for atrial fibrillation: Concomitant and sequential cohorts of the OPTION randomized controlled trial

左心耳封堵与口服抗凝治疗在房颤导管消融后的比较：OPTION随机对照试验的同期与序贯队列

Heart Rhythm
IF5.7
2025-04-250
PREAI
Walid Saliba; Devi Nair; Vijendra Swarup; Terri Hall; Vivek Iyer; Germán Calle Pérez; Stanislav Weiner; Manish Shah; Nilofar Islam; Marek Grygier; Brian Schuler; José Luis Ibáñez Criado; Guillaume Duthoit; Y Madhu Reddy; Vivek Y. Reddy; Moussa Mansour; Andrea Natale; Krystal Leger; Thomas Christen; Kenneth Stein; Brad Sutton; Oussama Wazni
Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma

局部晚期不可切除或转移性胃或胃食管交界处腺癌患者肿瘤中claudin 18亚型2的全球患病率

GASTRIC CANCER
IF5.1
2024-07-026
OAAI
Shitara, Kohei; Xu, Rui-Hua; Ajani, Jaffer A.; Moran, Diarmuid; Guerrero, Abraham; Li, Ran; Pavese, Janet; Matsangou, Maria; Bhattacharya, Pranob; Ueno, Yoko; Wang, Xuewei; Shah, Manish A.
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-03-0112
OAAI
Brahmer, Julie R.; Long, Georgina, V; Hamid, Omid; Garon, Edward B.; Herbst, Roy S.; Andre, Thierry; Armand, Philippe; Bajorin, Dean; Bellmunt, Joaquim; Burtness, Barbara; Choueiri, Toni K.; Cohen, Ezra E. W.; Diaz Jr, Luis A.; Shitara, Kohei; Kulkarni, Girish; McDermott, David; Shah, Manish; Tabernero, Josep; Vogel, Arndt; Zinzani, Pier Luigi; Jafari, Niusha; Birdu, Steven; Snyderu, Ellen; Gause, Christine; Braccou, Oswaldo L.; Pietanza, M. Catherine; Gruberu, Todd; Ribas, Antoni
Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
ANNALS OF ONCOLOGY
IF65.4
2023-11-012
PRE
Lordick, F.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; van Cutsem, E.; Gallego Plazas, J.; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Soo, H. H. F.; Turk, H. M.; Park, J. W.; Moran, D.; Bhattacharya, P.; Cao, Y. J.; Xu, R-H.
Updated efficacy and safety results from phase III SPOTLIGHT study evaluating zolbetuximab+mFOLFOX6 as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
ANNALS OF ONCOLOGY
IF65.4
2023-11-011
PRE
Ajani, J. A.; Lordick, F.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; van Cutsem, E.; Xu, R-H.; Aprile, G.; Xu, J.; Pazo Cid, R. A.; Kang, Y-K.; Yang, J.; Moran, D.; Bhattacharya, P.; Matsangou, M.; Arozullah, A.; Park, J. W.; Shitara, K.
Updated efficacy and safety results from phase III SPOTLIGHT study evaluating zolbetuximab+mFOLFOX6 as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
PRE
Ajani, J. A.; Lordick, F.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; Van Cutsem, E.; Xu, R-H.; Aprile, G.; Xu, J.; Cid, R. A. Pazo; Kang, Y-K.; Yang, J.; Moran, D.; Bhattacharya, P.; Matsangou, M.; Arozullah, A.; Park, J. W.; Shitara, K.
Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
PRE
Lordick, F.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Van Cutsem, E.; Plazas, J. Gallego; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Soo, H. H. F.; Turk, H. M.; Park, J. W.; Moran, D.; Bhattacharya, P.; Cao, Y. J.; Xu, R-H.
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
ONCOGENE
IF7.3
2023-09-2115
OAAI
Kasi, Pashtoon Murtaza; Hidalgo, Manuel; Jafari, Mehraneh D.; Yeo, Heather; Lowenfeld, Lea; Khan, Uqba; Nguyen, Alana T. H.; Siolas, Despina; Swed, Brandon; Hyun, Jini; Khan, Sahrish; Wood, Madeleine; Samstein, Benjamin; Rocca, Juan P.; Ocean, Allyson J.; Popa, Elizabeta C.; Hunt, Daniel H.; Uppal, Nikhil P.; Garrett, Kelly A.; Pigazzi, Alessio; Zhou, Xi Kathy; Shah, Manish A.; Hissong, Erika

研究方向

暂未获取到该数据
L
Laura H. Tang
H 指数:83论文数:542被引数:3.0万
D
David P. Kelsen
H 指数:87论文数:494被引数:2.2万
D
Daniel G. Coit
H 指数:99论文数:507被引数:4.1万
P
Peter C. Enzinger
H 指数:62论文数:352被引数:2.5万
E
Eric Van Cutsem
H 指数:174论文数:1,832被引数:17.4万
D
Doron Betel
H 指数:44论文数:224被引数:1.2万
M
Murray F. Brennan
H 指数:172论文数:1,212被引数:11.0万
P
Paraskevi Giannakakou
H 指数:59论文数:365被引数:1.4万
G
Giuseppe Galletti
H 指数:16论文数:106被引数:3,315
P
Prashant V. Thakkar
H 指数:8论文数:52被引数:773